Aurélie Mallinger

1.2k total citations
17 papers, 539 citations indexed

About

Aurélie Mallinger is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Aurélie Mallinger has authored 17 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Aurélie Mallinger's work include Synthetic Organic Chemistry Methods (3 papers), Cancer-related Molecular Pathways (3 papers) and Chemical synthesis and alkaloids (3 papers). Aurélie Mallinger is often cited by papers focused on Synthetic Organic Chemistry Methods (3 papers), Cancer-related Molecular Pathways (3 papers) and Chemical synthesis and alkaloids (3 papers). Aurélie Mallinger collaborates with scholars based in France, United Kingdom and Germany. Aurélie Mallinger's co-authors include Paul A. Clarke, Paul Workman, Steven R. Whittaker, Thierry Le Gall, Charles Mioskowski, Djordje Müsil, Dániel Schwarz, Kai Schiemann, Paul Czodrowski and Dirk Wienke and has published in prestigious journals such as The Journal of Physical Chemistry B, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Aurélie Mallinger

17 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélie Mallinger France 10 234 226 151 149 58 17 539
Morgan Pellerano France 12 213 0.9× 337 1.5× 104 0.7× 119 0.8× 72 1.2× 18 549
Camille Prével France 6 168 0.7× 204 0.9× 72 0.5× 100 0.7× 49 0.8× 8 371
Asako Nagata United States 8 266 1.1× 293 1.3× 151 1.0× 261 1.8× 41 0.7× 8 623
Kazuhiro Fukasawa Japan 11 203 0.9× 345 1.5× 183 1.2× 57 0.4× 68 1.2× 19 538
Smitha Kizhake United States 14 162 0.7× 310 1.4× 132 0.9× 71 0.5× 42 0.7× 20 490
Mari Ikuta Japan 8 169 0.7× 322 1.4× 215 1.4× 55 0.4× 65 1.1× 8 541
Venkat R. Pallela United States 17 208 0.9× 246 1.1× 278 1.8× 73 0.5× 49 0.8× 25 738
Robert H. Gruninger United States 13 234 1.0× 252 1.1× 345 2.3× 74 0.5× 73 1.3× 14 704
Christopher Meades United Kingdom 6 142 0.6× 182 0.8× 119 0.8× 58 0.4× 95 1.6× 8 347
Sarah J. Firdaus United States 6 192 0.8× 482 2.1× 71 0.5× 76 0.5× 47 0.8× 7 586

Countries citing papers authored by Aurélie Mallinger

Since Specialization
Citations

This map shows the geographic impact of Aurélie Mallinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Mallinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Mallinger more than expected).

Fields of papers citing papers by Aurélie Mallinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Mallinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Mallinger. The network helps show where Aurélie Mallinger may publish in the future.

Co-authorship network of co-authors of Aurélie Mallinger

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Mallinger. A scholar is included among the top collaborators of Aurélie Mallinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Mallinger. Aurélie Mallinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kinzel, Olaf, Christoph Steeneck, Simon Anderhub, et al.. (2020). Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold. Bioorganic & Medicinal Chemistry Letters. 33. 127738–127738. 4 indexed citations
2.
Hambruch, Nina, Barbara Herkert, Christian Gege, et al.. (2019). Abstract 3588: Identification of a potent, orally bioavailable and selective MCT4 Inhibitor for the treatment of solid Warburg tumors. 3588–3588. 1 indexed citations
3.
Hambruch, Nina, Barbara Herkert, Christian Gege, et al.. (2019). Abstract 3588: Identification of a potent, orally bioavailable and selective MCT4 Inhibitor for the treatment of solid Warburg tumors. Cancer Research. 79(13_Supplement). 3588–3588. 1 indexed citations
4.
Whittaker, Steven R., Aurélie Mallinger, Paul Workman, & Paul A. Clarke. (2017). Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacology & Therapeutics. 173. 83–105. 284 indexed citations
5.
Schiemann, Kai, Aurélie Mallinger, Dirk Wienke, et al.. (2016). Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 26(5). 1443–1451. 30 indexed citations
6.
Czodrowski, Paul, Aurélie Mallinger, Dirk Wienke, et al.. (2016). Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening. Journal of Medicinal Chemistry. 59(20). 9337–9349. 89 indexed citations
7.
Adeniji-Popoola, Olajumoke, Aurélie Mallinger, Sharon Gowan, et al.. (2016). Abstract 4355: Elucidation of the different roles of CDK8 and CDK19 in colorectal cancer (CRC) using CRISPR gene editing technology. Cancer Research. 76(14_Supplement). 4355–4355. 1 indexed citations
8.
Souchon, Vincent, Isabelle Leray, Bernard Valeur, et al.. (2010). Norbadione A: Kinetics and Thermodynamics of Cesium Uptake in Aqueous and Alcoholic Media. The Journal of Physical Chemistry B. 114(39). 12655–12665. 12 indexed citations
9.
Mallinger, Aurélie, et al.. (2010). One‐Pot Synthesis of 3‐Aryltetramic Acids. European Journal of Organic Chemistry. 2010(6). 1142–1148. 9 indexed citations
10.
Mallinger, Aurélie, et al.. (2010). Synthesis of Taurospongin A. Organic Letters. 12(12). 2818–2821. 9 indexed citations
11.
Beaudegnies, Renaud, et al.. (2010). Design and synthesis of novel spirocyclopropyl cyclohexane-1,3-diones and -1,3,5-triones for their incorporation into potent HPPD inhibitors. Tetrahedron Letters. 51(20). 2741–2744. 14 indexed citations
12.
Mallinger, Aurélie, et al.. (2008). Synthesis of Norbadione A. Synfacts. 2008(5). 445–445. 1 indexed citations
13.
Gall, Thierry Le, Aurélie Mallinger, & Charles Mioskowski. (2008). One-Pot Synthesis of Tetronic Acids from Esters. Synlett. 2008(3). 386–388. 6 indexed citations
14.
Mallinger, Aurélie, Thierry Le Gall, & Charles Mioskowski. (2008). ChemInform Abstract: One‐Pot Synthesis of Tetronic Acids from Esters.. ChemInform. 39(23). 1 indexed citations
15.
Mallinger, Aurélie, Thierry Le Gall, & Charles Mioskowski. (2008). 3-Aryltetronic Acids: Efficient Preparation and Use as Precursors for Vulpinic Acids. The Journal of Organic Chemistry. 74(3). 1124–1129. 34 indexed citations
16.
Mallinger, Aurélie, Marine Desage‐El Murr, Loı̈c Toupet, et al.. (2007). Total Synthesis of Norbadione A. The Journal of Organic Chemistry. 73(1). 22–26. 15 indexed citations
17.
Chrétien, Jean‐Mathieu, Aurélie Mallinger, Françoise Zammattio, et al.. (2007). Evaluation of polymer-supported vinyltin reagents in the Stille cross-coupling reaction. Tetrahedron Letters. 48(10). 1781–1785. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026